Abanmi Abdullah, Al Harthi Fahad, Al Baqami Riyadh, Al Assaf Saleh, Zouman Abdulrahman, Arfin Misbahul, Tariq Mohammad
Department of Dermatology, Armed Forces Hospital, Riyadh 11159, Saudi Arabia.
Arch Dermatol Res. 2006 Dec;298(7):347-52. doi: 10.1007/s00403-006-0699-4. Epub 2006 Sep 22.
HLA complex is composed of several closely linked loci, each containing several alleles, yielding a high expression of polymorphism. Vitiligo, a commonly acquired dermatological disorder, has been associated with different HLA antigens in different ethnic groups. In this study, HLA classes I (HLA-A, B, and C) and II (HLA-DR, DQ) antigens/alleles were analyzed in a group of 80 Saudi subjects consisting of vitiligo patients (40) and matched controls (40). The frequency of antigens of various HLA loci was tested using two-stage microcytotoxicity assays, while the frequency of alleles of HLA-DR was screened by polymerase chain reaction/sequence specific primers (PCR/SSP) method. The frequencies of HLA-B7, B15, Bw6, Cw6, Cw7, and DRB4010101 were found to be significantly higher in vitiligo patients compared to controls [P = 0.029, 0.015, 0.033, 0.009, 0.043, and 0.015, respectively, with relative risk (RR) > or = 3, etiologic fraction (EF) > or = 0.4]. On the other hand, HLA-A9, B5, DQ1, and DRB3010101 were significantly decreased in vitiligo patients compared to healthy Saudis [P = 0.008, 0.004, 0.028, and 0.04, respectively, with RR < 1 and preventive fraction (PF) < 0.5]. Among the patients, the highest allele frequency was noted for DRB4010101(70%), while in controls it was for DRB3010101 (72.5%). These results for antigens and allele frequency of various HLA Loci in vitiligo patients and control subjects suggested that HLA-B7, Bw6, Cw6, Cw7, and DRB4010101 could be susceptible to vitiligo, while HLA-A9, B5, DQ1, and DRB3010101 might be negatively associated with the development of vitiligo in Saudis.
人类白细胞抗原(HLA)复合体由几个紧密连锁的基因座组成,每个基因座包含多个等位基因,产生高度的多态性表达。白癜风是一种常见的后天性皮肤病,在不同种族群体中与不同的HLA抗原相关。在本研究中,对一组80名沙特受试者进行了HLA I类(HLA - A、B和C)和II类(HLA - DR、DQ)抗原/等位基因分析,其中包括白癜风患者(40名)和匹配的对照组(40名)。使用两阶段微量细胞毒性试验检测各种HLA基因座抗原的频率,而通过聚合酶链反应/序列特异性引物(PCR/SSP)方法筛选HLA - DR等位基因的频率。发现白癜风患者中HLA - B7、B15、Bw6、Cw6、Cw7和DRB4010101的频率显著高于对照组[P分别为0.029、0.015、0.033、0.009、0.043和0.015,相对危险度(RR)≥3,病因分值(EF)≥0.4]。另一方面,与健康沙特人相比,白癜风患者中HLA - A9、B5、DQ1和DRB3010101显著降低[P分别为0.008、0.004、0.028和0.04,RR<1且预防分值(PF)<0.5]。在患者中,DRB4010101的等位基因频率最高(70%),而在对照组中DRB3010101的等位基因频率最高(72.5%)。白癜风患者和对照受试者中各种HLA基因座的这些抗原和等位基因频率结果表明,HLA - B7、Bw6、Cw6、Cw7和DRB4010101可能易患白癜风,而HLA - A9、B5、DQ1和DRB3010101可能与沙特人白癜风的发生呈负相关。